insights_auto
Why is NOVOB80 up ၂.၃၃%?
Dive Deeperchevron_right
NOVOB80:BKK
NOVOB80 KTB DR
၁.၃၂ ฿
arrow_upward
+၂.၃၃%(+၀.၀၃၀) 1D
အောက် ၁၆, GMT+၇ ၀၂:၅၅:၃၀ · THB
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOVOB80...
Open
၁.၂၈ ฿
High
၁.၃၀ ฿
Low
၁.၂၇ ฿
Mkt. cap
ဋေ ၁.၃၂ သ
Avg. vol.
၃.၈၈ သန်း
Volume
၄.၃၅ သန်း
52-wk high
၂.၀၂ ฿
52-wk low
၁.၁၂ ฿
Shares outstanding
၃၀၀.၀၀ ဋေ
No. of employees
၇ သောင်း
Open
၁.၂၈ ฿
High
၁.၃၀ ฿
Low
၁.၂၇ ฿
Mkt. cap
ဋေ ၁.၃၂ သ
Avg. vol.
၃.၈၈ သန်း
Volume
၄.၃၅ သန်း
52-wk high
၂.၀၂ ฿
52-wk low
၁.၁၂ ฿
Shares outstanding
၃၀၀.၀၀ ဋေ
No. of employees
၇ သောင်း
News stories
From web sources and news partners
Simply Wall Street
·
ပြီးခဲ့သည့် ၇ နာရီ
Novo Nordisk (NVO) Stock May Be Undervalued As Buybacks Continue
The Motley Fool
·
ပြီးခဲ့သည့် ၁ ရက်
Novo Nordisk and Eli Lilly Just Got Some Fantastic News
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ ရက်
Novo Nordisk’s Growth Story Is Under Pressure as Eli Lilly Gains Ground
TradingKey
·
ပြီးခဲ့သည့် ၂ ရက်
Novo Nordisk A/S Stock (NVO) Moved Up by 3.38% on Oct 15: What Investors Need To Know
Profile
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark, and it became the highest valued company in Europe. Wikipedia
About NOVOB80 KTB DR
CEOMike Doustdar
Employees၆.၆၇ သောင်း
Founded၁၉၂၃
HeadquartersBagsværd, Capital Region of Denmark, ဒိန်းမတ်
Sector-
Websitenovonordisk.com